Current herpes vaccines
The strange thing is that there is already a vaccine around the herpes virus: this is called Zostavaks. The fact is that this is a vaccine designed to prevent shingles, also known as "herpes zoster" - yes, the herpes virus causes a disease that is usually found in people over 60 years old, usually called pebbles. In 2005, studying 38,000 elderly adults, Zostavax prevented 1/2 of the shingles and reduced the number of cases of postheptic neuralgia by 2/3. In October 2007, the vaccine was officially recommended in the United States for healthy adults aged 60 years and older. Now, obviously, the problem is that it is effective only against herpes zoster (shingles), not for herpes or herpes, but does not lose hope: it seems to me that the herpes vaccine is in the works, and when one of them develops successfully , another option for another version of the virus, for example, herpes, is just one step.
Vaccines must still be released.
A much more promising vaccine, which, as stated, could potentially turn into a vaccine against HSV-1 (herpes simplex virus type 1, the strain of the virus that causes herpes), is a vaccine that is currently being conducted in phase III studies. ; s are designed to be a vaccine to prevent genital herpes in women. Herpes Simplex Type 2 (HSV-2) is usually a herpes strain that causes genital herpes, but HSV-1 and HSV-2 are more than 99% genetically identical, and scientists who develop a vaccine say that: 1) never been exposed to HSV-1 or HSV-2 and 2) received the Herpevac vaccine, showed immunity to both strains of the virus.
This means that the Herpevac vaccine, which must be approved by the FDA in the near future, could potentially provide protection against HSV-1 if you have never been exposed to herpes (or strain), thereby keeping you from ever developing a cold sore, or getting genital herpes in this regard (good bonus right?).
If you want more information about traffic jam in the Herperwach or you really want to be a woman, then you can go to the official website of the National Institute of Health Herpevac Trial for Women at http://www.niaid.nih.gov/dmid/stds /herpevac/default.htm.
